Here are highlights from the most recent ASH meeting.

Radionuclide imaging agent Lexiscan is now commercially available.

This special report takes a look at the atrial fibrillation drugs in the pipeline.

A new software system, called CoagClinic, is helping hospitals manage their patients on anticoagulation therapy.

This article focuses on chronic heart failure and provides on overview of the disease, medication therapy management, and more.

Doing an ECG first before kids get ADHD drugs is the preferred course of treatment, say AAP and AHA.

Bayer will remove remaining supplies of Trasylol from market following the publication of negative study results.

A market research firm forecasts that more drug-eluting stents are on the way, which will bring down the costs of these devices.

The American College of Cardiology meeting spotlights ENHANCE study on Vytorin